124 results
Page 4 of 7
8-K
9cd5ema e7wo
25 Feb 19
Departure of Directors or Certain Officers
5:01pm
8-K
EX-99.1
izx dz7h42b
3 Dec 18
Other Events
4:06pm
8-K
EX-99.2
enfnd7muajn28h0ad
3 Dec 18
Other Events
4:06pm
8-K
EX-99.1
2r1fg50hv96xj l4a9aq
8 Nov 18
Karyopharm Reports Third Quarter 2018 Financial Results and Highlights Recent Company Progress
7:08am
8-K
EX-99.1
a8wtul5p di
11 Oct 18
Other Events
7:17am
8-K
EX-99.1
ykx pfy2p
9 Oct 18
Karyopharm Therapeutics Announces Proposed Private Offering of $150 Million of
4:10pm
8-K
EX-99.1
41gs53s u63cgom
9 Oct 18
Other Events
7:00am
424B5
291 l26ff
17 Aug 18
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
454tn60
7 Aug 18
Karyopharm Reports Second Quarter 2018 Financial Results and Highlights Recent Progress
7:18am
8-K
EX-99.1
wgm38sgmw45
6 Aug 18
Other Events
4:17pm
S-3ASR
nghnch58hz5pilnx4
2 Jul 18
Automatic shelf registration
4:08pm
8-K
EX-99.1
6d9wbv6ex0zft oowuo
24 May 18
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
s303b7vh rm6d11ckc
10 May 18
Karyopharm Reports First Quarter 2018 Financial Results and Highlights Recent Progress
7:11am
8-K
EX-99.1
dehj9o
3 May 18
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
5:02pm
424B5
ffmragyoe07r
3 May 18
Prospectus supplement for primary offering
5:00pm
424B5
11aga9ug
1 May 18
Prospectus supplement for primary offering
4:18pm